This content is machine translated Actinic keratoses Topical treatment options – an update Actinic keratoses are the most common dermatoses on chronically sun-damaged skin, especially in people with fair skin types. Prevalence increases significantly from the sixth decade of life. The spectrum of lesion-targeted…
View Post 8 min This content is machine translated Surgical techniques Dermatosurgery of skin tumors for practice In view of the massive increase in skin cancer, dermatosurgery is also gaining in importance. Many skin cancer patients can be diagnosed and treated with biopsies and excisions in the… CME-Test
View Post 6 min This content is machine translated Metastatic colorectal carcinoma A challenging opponent With a median survival of about two years, the prognosis for metastatic colorectal cancer remains poor. New therapeutic options have brought some improvement in recent years, but major breakthroughs have…
View Post 7 min This content is machine translated Lung tumors What’s new? Among the approximately 200 abstracts on thoracic oncology at this year’s ASCO Annual Meeting , exciting news was found especially on non-small cell lung cancer (NSCLC). With immunotherapeutic options in…
View Post 4 min This content is machine translated Non-resectable BRAF-mutated melanoma 5-year data from COLUMBUS study support continued long-term benefits After five years of follow-up in the COLUMBUS study, it is clear that patients with non-resectable or metastatic melanoma with a BRAFV600 mutation benefit long-term from encorafenib in combination with…
View Post 5 min This content is machine translated Multiple Myeloma Focus on first-line therapy The innovation of recent years has long since found its way into first-line therapy in multiple myeloma. Thus, the EHA-ESMO Guidelines were amended accordingly in January. Daratumumab, a monoclonal antibody…
View Post 5 min This content is machine translated Adjuvant melanoma treatment Interim analysis of “real world” data from the DACH region For the majority of melanoma patients, much more effective therapies are available today than a few years ago. This also applies to adjuvant melanoma treatment. Many new therapeutic approaches have…
View Post 8 min This content is machine translated News in metastatic prostate cancer. What impact will the studies published in 2020/2021 have on clinical practice? The years 2020 and 2021 have brought some novelties in metastatic prostate cancer. Thus, with 177Lutetium-PSMA-617and the PARP inhibitor Olaparib, two new active substances are available. The latter is already… CME-Test
View Post 6 min This content is machine translated CAR-T cell therapy Paving the way to success With the increasing clinical application of CAR-T cells, the practical aspects of therapy are a growing concern. Which patients should receive treatment using CAR-T cells outside of clinical trials? What…
View Post 1 min This content is machine translated Pan-European survey Management of tumor pain – patient care needs. Advances in tumor pain management, as well as the increasing number of long-term survivors, have contributed significantly to a better understanding of patients’ needs during the course of the disease.…
View Post 2 min This content is machine translated Multiple myeloma Small protein is difficult for phagocytes to digest Multiple myeloma is a type of bone marrow cancer that mainly affects people over the age of 60 and in many cases cannot be cured. Researchers at the University Hospital…
